Department of Molecular Pathology, Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Expert Rev Mol Diagn. 2013 Jul;13(6):527-8. doi: 10.1586/14737159.2013.811900.
The 20th annual Molecular Med Tri-Con conference, sponsored by Cambridge Health Institute (MA, USA), consisted of over 250 presentations within five parallel 'channels': 'Diagnostics, Therapeutics, Clinical, Informatics and Cancer', along with five preliminary symposia, 15 short courses, a plenary keynote session entitled 'Personalized Oncology - Fulfilling the Promise for Today's Patients' and a keynote panel entitled, 'Emerging Technologies and Industry Perspectives'. Over 3000 individuals from academia, clinical laboratories and industry were in attendance. This article will focus on the Keynote Session of 'Molecular Diagnostics' track within the Diagnostics Channel.
第 20 届年度分子医学三会议,由剑桥健康研究所(美国马萨诸塞州)主办,由五个平行的“频道”中的 250 多个演示组成:“诊断、治疗、临床、信息学和癌症”,以及五个初步研讨会,15 个短期课程,一个主题为“个性化肿瘤学-为今天的患者兑现承诺”的全体主题演讲和一个主题为“新兴技术和行业视角”的主题演讲小组。来自学术界、临床实验室和行业的 3000 多人出席了会议。本文将重点介绍诊断频道中分子诊断轨道的主题演讲环节。